亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy

医学 肝硬化 内科学 胃肠病学 重症监护医学
作者
Alberto Muñoz,Florencia Pollarsky,Mónica Marino,Mariano Cartier,Horacio Vázquez,Pablo Salgado,Gustavo Adolfo Sierra Romero
出处
期刊:World Journal of Gastroenterology [Baishideng Publishing Group Co]
卷期号:27 (28): 4639-4652 被引量:18
标识
DOI:10.3748/wjg.v27.i28.4639
摘要

This review summarizes the safety and efficacy of statins in patients with cirrhosis. Due to concerns about the safety of statins in patients with impaired liver function, they have recently been investigated as a potential treatment option in cirrhosis. The most clinically significant adverse event is statin-related myopathy, and this may be related to the high serum statin concentrations in the setting of severely impaired liver function. Rhabdomyolysis is the most serious and potentially life-threatening manifestation. It has recently been demonstrated that the recommended dose of simvastatin in patients with decompensated cirrhosis would be 20 mg/d because higher values, such as 40 mg/d, are associated with many adverse events, especially muscle injury. Likewise, simvastatin should not be administered to patients with Model for End-stage Liver Disease score > 12 and/or Child-Pugh class C because of the high risk of severe muscle injury. Due to the pleiotropic effects, the focus on statins has shifted from being considered harmful to something useful. Through these effects, statins could prevent liver-related morbidity and mortality in cirrhotic patients. Observational studies in large populations of patients with cirrhosis have shown that treatment with statins to decrease high cholesterol levels was associated with a reduced risk of hepatic decompensation, hepatocellular carcinoma development and death. The few randomized controlled trials in patients with cirrhosis and portal hypertension showed that statins lower portal pressure, quite likely through a reduction in hepatic resistance. Another large randomized controlled trial in patients with variceal bleeding showed that simvastatin in addition to standard of care did not prevent rebleeding but improved survival rate. Despite these encouraging outcomes, the quality of the evidence regarding the use of statins is low or very low due to the observational characteristics of most of the studies involved. Therefore, it is advisable to perform further randomized controlled trials on a large series of patients with hard clinical endpoints, using different statin types and varying doses. The objectives would be to prevent liver-related morbidity and mortality rather than treating cirrhosis complications to take additional information that makes it possible to add statins to the standard of care of these patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
酷酷的王完成签到 ,获得积分10
3秒前
6秒前
小胖完成签到 ,获得积分10
7秒前
12秒前
yyr完成签到 ,获得积分10
17秒前
20秒前
发嗲的凡蕾完成签到,获得积分20
22秒前
麒麟发布了新的文献求助10
24秒前
秋秋完成签到,获得积分10
36秒前
Fighting完成签到,获得积分10
40秒前
天天完成签到 ,获得积分10
47秒前
就晚安喽完成签到 ,获得积分10
47秒前
shuang完成签到 ,获得积分10
1分钟前
一木张完成签到,获得积分10
1分钟前
小泉完成签到 ,获得积分10
1分钟前
1分钟前
ly发布了新的文献求助10
1分钟前
无限如霜完成签到 ,获得积分10
1分钟前
梦华老师发布了新的文献求助10
1分钟前
1分钟前
Costing完成签到 ,获得积分10
1分钟前
贪玩的野狼完成签到 ,获得积分10
1分钟前
李李发布了新的文献求助10
1分钟前
淡然的咖啡豆完成签到 ,获得积分10
1分钟前
丘比特应助梦华老师采纳,获得10
2分钟前
2分钟前
梦华老师发布了新的文献求助10
2分钟前
gsgg完成签到 ,获得积分10
2分钟前
目目应助梦华老师采纳,获得10
2分钟前
哈哈哈哈完成签到 ,获得积分10
2分钟前
刀笔吏完成签到,获得积分10
2分钟前
jyy应助科研通管家采纳,获得10
2分钟前
香蕉觅云应助科研通管家采纳,获得10
2分钟前
共享精神应助科研通管家采纳,获得10
2分钟前
英姑应助科研通管家采纳,获得10
2分钟前
chen完成签到,获得积分10
2分钟前
wanci应助鹿芩采纳,获得10
2分钟前
清脆的柚子完成签到,获得积分10
3分钟前
基金中中中完成签到,获得积分10
3分钟前
Tiwiiw完成签到 ,获得积分10
3分钟前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Mechanistic Modeling of Gas-Liquid Two-Phase Flow in Pipes 2500
Kelsen’s Legacy: Legal Normativity, International Law and Democracy 1000
Conference Record, IAS Annual Meeting 1977 610
Interest Rate Modeling. Volume 3: Products and Risk Management 600
Interest Rate Modeling. Volume 2: Term Structure Models 600
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3544380
求助须知:如何正确求助?哪些是违规求助? 3121574
关于积分的说明 9347880
捐赠科研通 2819813
什么是DOI,文献DOI怎么找? 1550461
邀请新用户注册赠送积分活动 722559
科研通“疑难数据库(出版商)”最低求助积分说明 713273